COMPARING THE CLINICAL FEATURES AND OUTCOME IN PATIENTS WITH HEART ATTACK AND LOW BP, WHO COME TO THE HOSPITAL EARLY VERSUS THOSE WHO COME LATE.

Not Applicable

• Conditions: Health Condition 1: I210- ST elevation (STEMI) myocardial infarction of anterior wallHealth Condition 2: I211- ST elevation (STEMI) myocardial infarction of inferior wallHealth Condition 3: I212- ST elevation (STEMI) myocardial infarction of other sitesHealth Condition 4: I213- ST elevation (STEMI) myocardial infarction of unspecified site

• Registration Number: CTRI/2020/10/028222
• Lead Sponsor: KASTURBA MEDICAL COLLEGE MANIPAL MANIPAL ACADEMY OF HIGHER EDUCATION MANIPA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All Patients aged more than 18 years presenting to ER with chest pain and ECG diagnosis of STEMI and Cardiogenic shock

1. Patients with ECG diagnosis of STEMI defined as new ST segment elevation at J point in at least 2 contiguous leads of more than or equal to 2mm in

men more than 40 years and more than or equal to 1.5mm in women more than 40 years in leads V2-V3, and or more than 1mm in other contiguous chest /limb leads and

2. CS as defined by SCAI

- SBP less than 90mmHg or MAP less than 60 mmHg or more than 30mmHg drop from the baseline and drugs/device to maintain the BP

- Evidence of cardiac dysfunction â?? based on Echocardiographic findings

- Evidence of end organ hypoperfusion

3. Time to Hospitalisation since the onset of symptoms less than 24 hours for early presenters of cardiogenic shock and more than 24 hours for late presenters of cardiogenic shock.

Exclusion Criteria

1. Patients not giving informed written consent

2. Patients who are unable to document the symptom onset time

3. Shock due to causes other than STEMI

4. Patients with cardiac arrest before hospitalisation

5. Pregnant women, terminal illness and advanced malignancy.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Major adverse cardiovascular events (MACE) defined as a composite of all cause death, resuscitated cardiac arrest, nonfatal MI, strokeTimepoint: 1. End of hospital stay <br/ ><br>2. 1 month

Secondary Outcome Measures

Name	Time	Method
1. All cause death <br/ ><br>2. Resuscitated cardiac arrest <br/ ><br>3. Nonfatal MI <br/ ><br>4. Stroke <br/ ><br>5. Renal failureTimepoint: 1. End of hospital stay <br/ ><br>2. 1 month